» Articles » PMID: 21094887

Genetic and Epigenetic Underpinnings of Sex Differences in the Brain and in Neurological and Psychiatric Disease Susceptibility

Overview
Journal Prog Brain Res
Publisher Elsevier
Specialty Neurology
Date 2010 Nov 25
PMID 21094887
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

There are numerous examples of sex differences in brain and behavior and in susceptibility to a broad range of brain diseases. For example, gene expression is sexually dimorphic during brain development, adult life, and aging. These differences are orchestrated by the interplay between genetic, hormonal, and environmental influences. However, the molecular mechanisms that underpin these differences have not been fully elucidated. Because recent studies have highlighted the key roles played by epigenetic processes in regulating gene expression and mediating brain form and function, this chapter reviews emerging evidence that shows how epigenetic mechanisms including DNA methylation, histone modifications, and chromatin remodeling, and non-coding RNAs (ncRNAs) are responsible for promoting sexual dimorphism in the brain. Differential profiles of DNA methylation and histone modifications are found in dimorphic brain regions such as the hypothalamus as a result of sex hormone exposure during developmental critical periods. The elaboration of specific epigenetic marks is also linked with regulating sex hormone signaling pathways later in life. Furthermore, the expression and function of epigenetic factors such as the methyl-CpG-binding protein, MeCP2, and the histone-modifying enzymes, UTX and UTY, are sexually dimorphic in the brain. ncRNAs are also implicated in promoting sex differences. For example, X inactivation-specific transcript (XIST) is a long ncRNA that mediates X chromosome inactivation, a seminal developmental process that is particularly important in brain. These observations imply that understanding epigenetic mechanisms, which regulate dimorphic gene expression and function, is necessary for developing a more comprehensive view of sex differences in brain. These emerging findings also suggest that epigenetic mechanisms are, in part, responsible for the differential susceptibility between males and females that is characteristic of a spectrum of neurological and psychiatric disorders.

Citing Articles

The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms.

Scheinman S, Dong H J Alzheimers Dis. 2024; 102(3):562-576.

PMID: 39539121 PMC: 11721493. DOI: 10.1177/13872877241288709.


Unraveling the complexity of human brain: Structure, function in healthy and disease states.

Sultana O, Bandaru M, Islam M, Reddy P Ageing Res Rev. 2024; 100:102414.

PMID: 39002647 PMC: 11384519. DOI: 10.1016/j.arr.2024.102414.


The Heterogeneity of Post-Menopausal Disease Risk: Could the Basis for Why Only Subsets of Females Are Affected Be Due to a Reversible Epigenetic Modification System Associated with Puberty, Menstrual Cycles, Pregnancy and Lactation, and,....

Hart D Int J Mol Sci. 2024; 25(7).

PMID: 38612676 PMC: 11011715. DOI: 10.3390/ijms25073866.


Multigenerational association between smoking and autism spectrum disorder: findings from a nationwide prospective cohort study.

Yim G, Roberts A, Lyall K, Ascherio A, Weisskopf M Am J Epidemiol. 2024; 193(8):1115-1126.

PMID: 38583942 PMC: 11299032. DOI: 10.1093/aje/kwae038.


Sex-Biased Expression and Response of microRNAs in Neurological Diseases and Neurotrauma.

Geleta U, Prajapati P, Bachstetter A, Nelson P, Wang W Int J Mol Sci. 2024; 25(5).

PMID: 38473893 PMC: 10931569. DOI: 10.3390/ijms25052648.


References
1.
Santos C, Rodriguez-Revenga L, Madrigal I, Badenas C, Pineda M, Mila M . A novel mutation in JARID1C gene associated with mental retardation. Eur J Hum Genet. 2006; 14(5):583-6. DOI: 10.1038/sj.ejhg.5201608. View

2.
Nishino K, Hattori N, Tanaka S, Shiota K . DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J Biol Chem. 2004; 279(21):22306-13. DOI: 10.1074/jbc.M309513200. View

3.
Niino M, Hirotani M, Fukazawa T, Kikuchi S, Sasaki H . Estrogens as potential therapeutic agents in multiple sclerosis. Cent Nerv Syst Agents Med Chem. 2009; 9(2):87-94. DOI: 10.2174/187152409788452054. View

4.
Mehler M . Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol. 2008; 86(4):305-41. PMC: 2636693. DOI: 10.1016/j.pneurobio.2008.10.001. View

5.
Gregg C, Zhang J, Butler J, Haig D, Dulac C . Sex-specific parent-of-origin allelic expression in the mouse brain. Science. 2010; 329(5992):682-5. PMC: 2997643. DOI: 10.1126/science.1190831. View